SCHEMBL7773121

SCHEMBL7773121

Cn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccncc2)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.45
CA12 O43570 4/20 0.44
CA9 Q16790 4/20 0.44
CA1 P00915 4/20 0.43
CA2 P00918 4/20 0.43
LDHA P00338 1/20 0.42
LDHB P07195 1/20 0.42
LRRK2 Q5S007 2/20 0.42
PTGS2 P35354 6/20 0.41
PTGS1 P23219 4/20 0.41
CA14 Q9ULX7 2/20 0.41
KMT2A Q03164 1/20 0.41
MT-CO2 P00403 1/20 0.41
LMNA P02545 1/20 0.41
CA3 P07451 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CHRM1 P11229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779465 1.00 MAPK14 (0.45) MAPK14CA12CA9CA1CA2
SCHEMBL7779780 0.90 IKBKB (0.46) MAPK14CA12CA9CA1CA2
SCHEMBL7773321 0.90 IKBKB (0.46) MAPK14CA12CA9CA1CA2
SCHEMBL8166784 0.89 KMT2A (0.52) CA12CA9CA1CA2PTGS2
SCHEMBL7777656 0.89 PTGS2 (0.46) MAPK14CA12CA9PTGS2PTGS1
SCHEMBL7773091 0.89 PTGS2 (0.46) MAPK14CA12CA9PTGS2PTGS1
SCHEMBL8179845 0.88 PTGS2 (0.55) CA12CA9CA1CA2PTGS2
SCHEMBL7799176 0.87 CA12 (0.47) MAPK14CA12CA9CA1CA2
SCHEMBL7779964 0.87 MAPK14 (0.43) MAPK14CA12CA9CA1CA2
SCHEMBL7780594 0.87 BRAF (0.44) MAPK14CA12CA9CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP claimed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP claimed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed